Patterson Companies Inc (PDCO) Stock
PDCO is no longer traded. Patterson Companies was taken private by Patient Square Capital on April 17, 2025.
Each PDCO share was exchanged for $31.35 in cash. Prices on this page are historical; the last trade was April 16, 2025 at $31.33.
Patterson Companies stock price history
PDCO final trading statistics
- Final close
- $31.33
- Final trading day
- Apr 16, 2025
- Market cap at delisting
- $2.77B
- Shares outstanding
- 88.47M
- Final 52-week range
- $19.45 – $31.79
- Avg. volume (final 3 mo.)
- 1,661,796
- All-time high (split-adj.)
- $36.75 · Aug 2015
- All-time low (split-adj.)
- $1.21 · Nov 1992
- Return since IPO
- +2337.4%
- Beta
- 0.72
- Book value / share
- $11.19
- Price / book
- 2.80
Patterson Companies annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $6.57B | $185.9M | $2.31 |
| FY2023 | $6.47B | $207.6M | $2.41 |
| FY2022 | $6.50B | $203.2M | $2.27 |
| FY2021 | $5.91B | $156.0M | $1.92 |
| FY2020 | $5.49B | -$589.4M | $1.56 |
Last five fiscal years reported before the delisting; fiscal year ending April. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Patterson Companies Inc
Patterson Companies, Inc. engages in the distribution of dental and animal health products. The company operates through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; and practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, and patient engagement solutions, as well as clinical and patient education systems. This segment also provides a range of related services comprising software and design, maintenance and repair, and equipment financing services. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, and equipment, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. Patterson Companies, Inc. was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is based in Saint Paul, Minnesota with additional locations in Loveland, Colorado; Edmonton, Alberta; Stoke-on-Trent, United Kingdom.
Patterson Companies stock FAQ
What happened to Patterson Companies stock?
Patterson Companies was taken private by Patient Square Capital on April 17, 2025. Shareholders received $31.35 in cash for each share. PDCO stock stopped trading on the Nasdaq, with a final close of $31.33 on April 16, 2025.
What did Patterson Companies shareholders receive?
Each PDCO share was converted into $31.35 in cash.
Is PDCO stock still trading?
No. PDCO was delisted from the Nasdaq on April 17, 2025 and no longer trades on a U.S. exchange.
What was the last price of PDCO stock?
PDCO closed at $31.33 on its final trading day, April 16, 2025, for a market value of about $2.77B.
What were Patterson Companies's revenue and earnings in its last full fiscal year?
Patterson Companies reported revenue of $6.57B and net income of $185.9M in fiscal 2024, its last full year as a public company.
When did Patterson Companies go public?
Patterson Companies Inc stock began trading on October 28, 1992.